Lista de obras - John Corkery - Dominio Público Uruguay

"Legal highs": safe and legal "heavens"? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK

artículo científico publicado en 2014

"Spice," "kryptonite," "black mamba": an overview of brand names and marketing strategies of novel psychoactive substances on the web.

artículo científico

'New/Designer Benzodiazepines': an analysis of the literature and psychonauts' trip reports

scientific article published on 10 January 2020

2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): A preliminary review.

artículo científico

4,4'-Dimethylaminorex ("4,4'-DMAR"; "Serotoni") misuse: A Web-based study.

artículo científico publicado en 2017

5,6-Methylenedioxy-2-aminoindane: from laboratory curiosity to 'legal high'.

artículo científico publicado en 2012

A matter of life and death: substance-caused and substance-related fatalities in Ibiza in 2015.

artículo científico publicado en 2017

An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions

artículo científico publicado en 2019

An index of fatal toxicity for drugs of misuse.

artículo científico publicado en 2010

An index of fatal toxicity for new psychoactive substances.

artículo científico publicado en 2018

An insight into the deep web; why it matters for addiction psychiatry?

artículo científico publicado en 2017

Assessing the 2004-2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems

scientific article published on 01 February 2019

Buprenorphine mortality, seizures and prescription data in the UK, 1980-2002.

artículo científico publicado en 2005

Bupropion perceived as a stimulant by two patients with a previous history of cocaine misuse

artículo científico publicado en 2013

Cannabis; Epidemiological, Neurobiological and Psychopathological Issues: An Update

artículo científico publicado en 2017

Characteristics of deaths associated with kratom use

scientific article published on 20 August 2019

Cocaine-related health emergencies in Europe: a review of sources of information, trends and implications for service development

artículo científico publicado en 2012

Cocaine/crack cocaine consumption, treatment demand, seizures, related offences, prices, average purity levels and deaths in the UK (1990 - 2004).

artículo científico publicado en 2008

Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002.

artículo científico publicado en 2003

Deaths in the Lesbian, Gay, Bisexual and Transgender United Kingdom communities associated with GHB and precursors.

artículo científico publicado en 2017

Deaths of individuals aged 16-24 years in the UK after using mephedrone

artículo científico publicado en 2015

Deaths of opiate/opioid misusers involving dihydrocodeine, UK, 1997-2007.

artículo científico publicado en 2011

Drug abuse-related mortality: a study of teenage addicts over a 20-year period.

artículo científico publicado en 1999

Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003).

artículo científico publicado en 2006

Estimating prevalence of problematic drug use: comments on Frischer et al.

artículo científico publicado en 2002

Evolutionary Considerations on the Emerging Subculture of the E-psychonauts and the Novel Psychoactive Substances: A Comeback to the Shamanism?

artículo científico publicado en 2016

Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances

artículo científico publicado en 2020

Fatal injuries while under the influence of psychoactive drugs: a cross-sectional exploratory study in England

artículo científico publicado en 2006

Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database

artículo científico publicado en 2020

From concept(ion) to life after death/the grave: The 'natural' history and life cycle(s) of novel psychoactive substances (NPS).

artículo científico publicado en 2017

Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use.

artículo científico

How deaths can help clinicians and policy-makers understand the risks of novel psychoactive substances

scientific article published on 14 January 2020

Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers

scientific article published on 12 October 2018

Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances

artículo científico publicado en 2020

Intended and unintended use of cathinone mixtures

artículo científico publicado en 2017

Is there a Teratogenicity Risk Associated with Cannabis and Synthetic Cannabimimetics' ('Spice') Intake?

artículo científico publicado en 2017

Is there a potential of misuse for Magnolia officinalis compounds/metabolites?

artículo científico

Legal highs: a problem of definitions?

artículo científico publicado en 2014

Loss of materials and resources for addiction researchers: comment on Mitchell et al. (2012).

artículo científico publicado en 2013

MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; 'sparkle'; 'mindy') toxicity: a brief overview and update

artículo científico

Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues.

artículo científico publicado en 2010

Methoxetamine-related deaths in the UK: an overview.

artículo científico publicado en 2015

New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic').

artículo científico publicado en 2005

New/emerging psychoactive substances and associated psychopathological consequences

artículo científico publicado en 2019

New/emerging psychoactive substances and associated psychopathological consequences - Corrigendum

scientific article published on 12 September 2019

Novel Opioids: Systematic Web Crawling Within the e-Psychonauts' Scenario

scientific article published on 18 March 2020

Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey.

artículo científico publicado en 2013

Novel psychoactive substances of interest for psychiatry.

artículo científico publicado en 2015

Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.

artículo científico publicado en 2016

Overview of amphetamine-type stimulant mortality data--UK, 1997-2007.

artículo científico publicado en 2010

Overview of literature and information on "khat-related" mortality: a call for recognition of the issue and further research.

artículo científico publicado en 2011

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FA

artículo científico publicado en 2022

Phenazepam abuse in the UK: an emerging problem causing serious adverse health problems, including death

artículo científico publicado en 2012

Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine

artículo científico publicado en 2012

Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project

artículo científico publicado en 2013

Suicide among drug addicts in the UK.

artículo científico publicado en 1999

Suicide verdicts as opposed to accidental deaths in substance-related fatalities (UK, 2001-2007).

artículo científico publicado en 2011

Suspected and Confirmed Fatalities Associated With Mephedrone (4-Methylmethcathinone, “Meow Meow”) in the United Kingdom ⬇️

artículo científico publicado el 1 de octubre de 2012

The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.

artículo científico publicado en 2017

The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective

scientific article published on 20 November 2019

The clinical challenges of synthetic cathinones

scientific article published on 03 February 2020

The consequences of drug misuse on post-marketing surveillance

artículo científico publicado en 2016

The recreational tryptamine 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine): A brief review ⬇️

artículo científico publicado el 7 de junio de 2012

Trapped in the "K-hole": overview of deaths associated with ketamine misuse in the UK (1993-2006).

artículo científico publicado en 2008

Use of benzylglycinamide by a HIV-seropositive polysubstance user: The changing pattern of novel psychoactive substance use among youths

artículo científico publicado en 2016

Venlafaxine as the 'baby ecstasy'? Literature overview and analysis of web-based misusers' experiences.

artículo científico

Lista de obras de John Corkery

"Legal highs": safe and legal "heavens"? A study on the diffusion, knowledge and risk awareness of novel psychoactive drugs among students in the UK

"Spice," "kryptonite," "black mamba": an overview of brand names and marketing strategies of novel psychoactive substances on the web.

'New/Designer Benzodiazepines': an analysis of the literature and psychonauts' trip reports

2-DPMP (desoxypipradrol, 2-benzhydrylpiperidine, 2-phenylmethylpiperidine) and D2PM (diphenyl-2-pyrrolidin-2-yl-methanol, diphenylprolinol): A preliminary review.

4,4'-Dimethylaminorex ("4,4'-DMAR"; "Serotoni") misuse: A Web-based study.

5,6-Methylenedioxy-2-aminoindane: from laboratory curiosity to 'legal high'.

A matter of life and death: substance-caused and substance-related fatalities in Ibiza in 2015.

An Insight into Z-Drug Abuse and Dependence: An Examination of Reports to the European Medicines Agency Database of Suspected Adverse Drug Reactions

An index of fatal toxicity for drugs of misuse.

An index of fatal toxicity for new psychoactive substances.

An insight into the deep web; why it matters for addiction psychiatry?

Assessing the 2004-2018 Fentanyl Misusing Issues Reported to an International Range of Adverse Reporting Systems

Buprenorphine mortality, seizures and prescription data in the UK, 1980-2002.

Bupropion perceived as a stimulant by two patients with a previous history of cocaine misuse

Cannabis; Epidemiological, Neurobiological and Psychopathological Issues: An Update

Characteristics of deaths associated with kratom use

Cocaine-related health emergencies in Europe: a review of sources of information, trends and implications for service development

Cocaine/crack cocaine consumption, treatment demand, seizures, related offences, prices, average purity levels and deaths in the UK (1990 - 2004).

Death rates from ecstasy (MDMA, MDA) and polydrug use in England and Wales 1996-2002.

Deaths in the Lesbian, Gay, Bisexual and Transgender United Kingdom communities associated with GHB and precursors.

Deaths of individuals aged 16-24 years in the UK after using mephedrone

Deaths of opiate/opioid misusers involving dihydrocodeine, UK, 1997-2007.

Drug abuse-related mortality: a study of teenage addicts over a 20-year period.

Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003).

Estimating prevalence of problematic drug use: comments on Frischer et al.

Evolutionary Considerations on the Emerging Subculture of the E-psychonauts and the Novel Psychoactive Substances: A Comeback to the Shamanism?

Exploring the Baseline Knowledge and Experience of Healthcare Professionals in the United Kingdom on Novel Psychoactive Substances

Fatal injuries while under the influence of psychoactive drugs: a cross-sectional exploratory study in England

Focus on Clozapine Withdrawal- and Misuse-Related Cases as Reported to the European Medicines Agency (EMA) Pharmacovigilance Database

From concept(ion) to life after death/the grave: The 'natural' history and life cycle(s) of novel psychoactive substances (NPS).

Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4-butanediol (1,4-BD; BDO): A literature review with a focus on UK fatalities related to non-medical use.

How deaths can help clinicians and policy-makers understand the risks of novel psychoactive substances

Ibogaine as a treatment for substance misuse: Potential benefits and practical dangers

Impact of the UK Psychoactive Substances Act on awareness, use, experiences and knowledge of potential associated health risks of novel psychoactive substances

Intended and unintended use of cathinone mixtures

Is there a Teratogenicity Risk Associated with Cannabis and Synthetic Cannabimimetics' ('Spice') Intake?

Is there a potential of misuse for Magnolia officinalis compounds/metabolites?

Legal highs: a problem of definitions?

Loss of materials and resources for addiction researchers: comment on Mitchell et al. (2012).

MDAI (5,6-methylenedioxy-2-aminoindane; 6,7-dihydro-5H-cyclopenta[f][1,3]benzodioxol-6-amine; 'sparkle'; 'mindy') toxicity: a brief overview and update

Mephedrone (4-methylmethcathinone; 'meow meow'): chemical, pharmacological and clinical issues.

Methoxetamine-related deaths in the UK: an overview.

New trends in the cyber and street market of recreational drugs? The case of 2C-T-7 ('Blue Mystic').

New/emerging psychoactive substances and associated psychopathological consequences

New/emerging psychoactive substances and associated psychopathological consequences - Corrigendum

Novel Opioids: Systematic Web Crawling Within the e-Psychonauts' Scenario

Novel psychoactive substances as a novel challenge for health professionals: results from an Italian survey.

Novel psychoactive substances of interest for psychiatry.

Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.

Overview of amphetamine-type stimulant mortality data--UK, 1997-2007.

Overview of literature and information on "khat-related" mortality: a call for recognition of the issue and further research.

Pharmacovigilance Signals of the Opioid Epidemic over 10 Years: Data Mining Methods in the Analysis of Pharmacovigilance Datasets Collecting Adverse Drug Reactions (ADRs) Reported to EudraVigilance (EV) and the FDA Adverse Event Reporting System (FA

Phenazepam abuse in the UK: an emerging problem causing serious adverse health problems, including death

Phenomenon of new drugs on the Internet: the case of ketamine derivative methoxetamine

Promoting innovation and excellence to face the rapid diffusion of novel psychoactive substances in the EU: the outcomes of the ReDNet project

Suicide among drug addicts in the UK.

Suicide verdicts as opposed to accidental deaths in substance-related fatalities (UK, 2001-2007).

Suspected and Confirmed Fatalities Associated With Mephedrone (4-Methylmethcathinone, “Meow Meow”) in the United Kingdom ⬇️

The "Endless Trip" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.

The Bridge Between Classical and "Synthetic"/Chemical Psychoses: Towards a Clinical, Psychopathological, and Therapeutic Perspective

The clinical challenges of synthetic cathinones

The consequences of drug misuse on post-marketing surveillance

The recreational tryptamine 5-MeO-DALT (N,N-diallyl-5-methoxytryptamine): A brief review ⬇️

Trapped in the "K-hole": overview of deaths associated with ketamine misuse in the UK (1993-2006).

Use of benzylglycinamide by a HIV-seropositive polysubstance user: The changing pattern of novel psychoactive substance use among youths

Venlafaxine as the 'baby ecstasy'? Literature overview and analysis of web-based misusers' experiences.